The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this method offers a simpler way to deliver GLP-1 https://sahilzuho128933.verybigblog.com/39801407/glp-1-patches-a-novel-approach-to-diabetes-management